CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, July 29th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...